• Investors
  • News
  • Careers
  • Contact
Vaxart Home Button
  • Global Need
    • Vaccines
    • History & Impact
  • Our Solution
    • Oral Vaccines
    • Technology
    • Vaccine Advantages
    • Platform Advantages
  • Pipeline
    • Research & Development
    • Norovirus
    • Influenza
    • RSV
    • HPV
  • About Us
    • Our Mission
    • Our Team
    • Careers
    • Contact
    • Compliance
  • Investors
  • News
  • Careers
  • Contact

Single

Today

Vaccines continue to be a topic of great interest to both citizens and healthcare professionals. Vaccination has substantially reduced the morbidity and mortality caused by infectious diseases, and yearly influenza vaccinations have become commonplace. Preventable diseases remain a significant issue, however, in many areas of the world where infrastructures for vaccination are poor and vaccines cannot be delivered where they are most needed. The future of immunization now looks to vaccines that are simple to administer, survive transport without refrigeration, and provide a long-lasting immune response.

Reference: Berche P. Clin Microbiol Infect. 2012;18(Suppl 5):1-6.

Post navigation

Previous PostPrevious
Next PostNext
Media Contacts

Katie Hogan, WCG
415.658.9745
khogan@wcgworld.com

Samir Singh, Vaxart
908.720.622,4
ssignh@vaxart.com

Get Updates

Subscribe to receive news alerts now.

© 2022 Vaxart, Inc., All rights reserved. Terms of UsePrivacy Policy